ArticleCureus2025
The Impact of Allergic Rhinitis on the Quality of Life Among Adult Patients in Alahsa, Saudi Arabia: A Case-Control Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and objective Allergic rhinitis (AR) is highly prevalent in Saudi Arabia, yet its broader consequences on adult well-being remain underexplored. In this study, we aimed to compare health-related quality of life (HRQoL), psychological distress, and insomnia between adults with and without AR in Alahsa, Saudi Arabia. Methods A retrospective case-control study was conducted from December 2024 to May 2025. Fifty adults (≥18 years) with the International Classification of Diseases, 10th revision (ICD-10)-confirmed AR were randomly selected from Al Jabr Eye and ENT Hospital records; 150 controls without AR or chronic illness were recruited from the general community (1:3 ratio). Participants completed the General Health Questionnaire-12 (GHQ-12), Athens Insomnia Scale (AIS), and mini Rhinoconjunctivitis Quality of Life Questionnaire (miniRQLQ). Between-group differences were analysed with χ² or independent t-tests; Pearson correlations were employed to assess associations among scales. Results Cases and controls were comparable in age (mean age: 35.5 ± 11.2 vs. 34.6 ± 11.6 years, respectively) and sex distribution [23 males (46%)]. A significant difference was noted in educational level (p=0.023). AR cases scored significantly worse on all GHQ-12 items (p<0.001); 19 (38%) met the threshold for mild-to-moderate psychological distress vs. eight (5%) among controls. Clinically relevant insomnia (AIS ≥6) was present in 39 (78%) of cases and 34 (23%) of controls (p<0.001). Mean miniRQLQ domains most affected were tiredness/fatigue (2.98 ± 1.73) and sleep difficulty (2.80 ± 1.98). AIS scores correlated moderately with miniRQLQ scores in cases (r=0.40, p=0.006). Conclusions Based on our findings, AR imposes substantial burdens on mental health, sleep quality, and daily functioning among Saudi adults. Multidisciplinary management, including behavioural sleep counseling and psychological support, should accompany pharmacotherapy to reduce the societal impact of AR.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.